Literature DB >> 8432912

Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research.

K J Smith1, H G Skelton, J Yeager, D Baxter, P Angritt, S Johnson, C N Oster, K F Wagner.   

Abstract

BACKGROUND: As part of a military study of the natural history of human immunodeficiency virus type 1 (HIV-1) disease, all patients entered in the study were examined for cutaneous changes associated with HIV-1 infection.
OBJECTIVE: Our purpose was to characterize and record the types of inflammatory dermatoses in a large number of HIV-1-infected patients to determine whether there was a correlation with the stage of disease.
METHODS: The clinical findings in each case were compared with the results of cultures and biopsy specimens and correlated with Walter Reed stage.
RESULTS: Most of the inflammatory dermatoses were maculopapular eruptions often with prominent follicular involvement, and in some there was a lichenoid component. With increasing Walter Reed stage, many eruptions become papulosquamous, some with psoriasiform scale and some with a hypertrophic lichenoid appearance.
CONCLUSION: Although most of the inflammatory eruptions were nonspecific clinically, most cases showed features resembling those in graft-versus-host disease.

Entities:  

Mesh:

Year:  1993        PMID: 8432912     DOI: 10.1016/0190-9622(93)70023-m

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Red fingers syndrome and HIV infection.

Authors:  Vânia Oliveira Carvalho; Cristina Rodrigues Cruz; Leide Parolin Marinoni; Betina Werner; Tony Tanous Tahan; Hermênio Cavalcante Lima
Journal:  Arch Dis Child       Date:  2007-06       Impact factor: 3.791

2.  Mucocutaneous diseases in drug addicts with or without HIV infection. A case-control study.

Authors:  G B Gaeta; A Maisto; C Sichenze; R A Satriano; C Sardaro; G Giusti
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.